The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Timothy R. Rebbeck

Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology

University of Pennsylvania

Philadelphia

USA

[email]@*.med.upenn.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA. 2000 - 2007

References

  1. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk. Rebbeck, T.R., Troxel, A.B., Norman, S., Bunin, G., DeMichele, A., Schinnar, R., Berlin, J.A., Strom, B.L. Am. J. Epidemiol. (2007) [Pubmed]
  2. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Rebbeck, T.R., Troxel, A.B., Norman, S., Bunin, G.R., DeMichele, A., Baumgarten, M., Berlin, M., Schinnar, R., Strom, B.L. Int. J. Cancer (2007) [Pubmed]
  3. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Rebbeck, T.R., Troxel, A.B., Walker, A.H., Panossian, S., Gallagher, S., Shatalova, E.G., Blanchard, R., Norman, S., Bunin, G., DeMichele, A., Berlin, M., Schinnar, R., Berlin, J.A., Strom, B.L. Cancer Epidemiol. Biomarkers Prev. (2007) [Pubmed]
  4. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk. Rebbeck, T.R., Troxel, A.B., Shatalova, E.G., Blanchard, R., Norman, S., Bunin, G., Demichele, A., Schinnar, R., Berlin, J.A., Strom, B.L. Cancer Epidemiol. Biomarkers Prev. (2007) [Pubmed]
  5. Genetics, epidemiology, and cancer disparities: is it black and white?. Rebbeck, T.R., Halbert, C.H., Sankar, P. J. Clin. Oncol. (2006) [Pubmed]
  6. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Rebbeck, T.R., Troxel, A.B., Wang, Y., Walker, A.H., Panossian, S., Gallagher, S., Shatalova, E.G., Blanchard, R., Bunin, G., DeMichele, A., Rubin, S.C., Baumgarten, M., Berlin, M., Schinnar, R., Berlin, J.A., Strom, B.L. J. Natl. Cancer Inst. (2006) [Pubmed]
  7. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Rebbeck, T.R., Friebel, T., Wagner, T., Lynch, H.T., Garber, J.E., Daly, M.B., Isaacs, C., Olopade, O.I., Neuhausen, S.L., van 't Veer, L., Eeles, R., Evans, D.G., Tomlinson, G., Matloff, E., Narod, S.A., Eisen, A., Domchek, S., Armstrong, K., Weber, B.L. J. Clin. Oncol. (2005) [Pubmed]
  8. Ethnicity, ancestry, and race in molecular epidemiologic research. Rebbeck, T.R., Sankar, P. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  9. Biomarkers of inherited susceptibility and cancer. Rebbeck, T.R. IARC Sci. Publ. (2004) [Pubmed]
  10. SNPs, haplotypes, and cancer: applications in molecular epidemiology. Rebbeck, T.R., Ambrosone, C.B., Bell, D.A., Chanock, S.J., Hayes, R.B., Kadlubar, F.F., Thomas, D.C. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  11. Assessing the function of genetic variants in candidate gene association studies. Rebbeck, T.R., Spitz, M., Wu, X. Nat. Rev. Genet. (2004) [Pubmed]
  12. Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk. Rebbeck, T.R. Environ. Mol. Mutagen. (2002) [Pubmed]
  13. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. Rebbeck, T.R., Lynch, H.T., Neuhausen, S.L., Narod, S.A., Van't Veer, L., Garber, J.E., Evans, G., Isaacs, C., Daly, M.B., Matloff, E., Olopade, O.I., Weber, B.L. N. Engl. J. Med. (2002) [Pubmed]
  14. The contribution of inherited genotype to breast cancer. Rebbeck, T.R. Breast Cancer Res. (2002) [Pubmed]
  15. P gene as an inherited biomarker of human eye color. Rebbeck, T.R., Kanetsky, P.A., Walker, A.H., Holmes, R., Halpern, A.C., Schuchter, L.M., Elder, D.E., Guerry, D. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  16. Inherited genotype and prostate cancer outcomes. Rebbeck, T.R. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  17. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Rebbeck, T.R., Wang, Y., Kantoff, P.W., Krithivas, K., Neuhausen, S.L., Godwin, A.K., Daly, M.B., Narod, S.A., Brunet, J.S., Vesprini, D., Garber, J.E., Lynch, H.T., Weber, B.L., Brown, M. Cancer Res. (2001) [Pubmed]
  18. Association of HPC2/ELAC2 genotypes and prostate cancer. Rebbeck, T.R., Walker, A.H., Zeigler-Johnson, C., Weisburg, S., Martin, A.M., Nathanson, K.L., Wein, A.J., Malkowicz, S.B. Am. J. Hum. Genet. (2000) [Pubmed]
  19. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Rebbeck, T.R. J. Clin. Oncol. (2000) [Pubmed]
  20. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Rebbeck, T.R., Levin, A.M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J.E., Godwin, A.K., Daly, M.B., Narod, S.A., Neuhausen, S.L., Lynch, H.T., Weber, B.L. J. Natl. Cancer Inst. (1999) [Pubmed]
 
WikiGenes - Universities